RE:RE:RE:RE:RE:RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A Deals I agree, could be hearing about accelerated approval Monday.
or anytime.
Regarding " control of the company".
Thst process would create an instant increase in SP.
Asumming one is talking about an un negotiated takeover?
Aquiring the volume of shares would in- of- itself drive the price uP.
People have to realize, The recent trading activity has been anemic volume.
Trying to acquire 10% of the float would require buying about 8 ,million shares.
That activity as I said would elevate the price.
So an open market buyout is not coming up with $$ and just buying the shares. The market price is not fixed & would react.
How about an unsoliced " offer"?
The aquiring entity would need to make that offer to the shareholders via a public statement.
The B.O.D. Would publicly approve or disapprove with justifiable reasoning.
Lets, walk that road for a moment ( BTW I was a shareholder of a comany taken over in such a way).
First if all a market price offer would not be approved or accepted by even close to a small % of shareholders.
The lowest analyst target right now is $6ps.
Some shareholders would jump at that, but again not even close to enough to create a significant % of ownership.
however, such an offer made public & with B.O.D. Recommendation against would at that moment of time establish $6ps as the market trading floor.
many options at that moment.
1. Onc could be approached by a white knight, offering obviously more.
2. Onc could announce " hiring outside consulting to evaluate fair market value".
3. Potential takeover company could raise the offer & apeal direct to shareholders.
4. whole event could die on the vine.
5. Onc could look to finance a holding company & take private with, again an offer higher than the potential takeover offer.
regardles, thinking you could walk in & acquire Onc for its existing market cap is impossible.
The SP is in no way indicative of the true value of the company.
Have doubts?
Rustle up some $$ and buy yourself 100k shares.
or even be real bold, get 10% of the company.
That news alone would elevate the price.
I have owned shares of about 7-8 public companies that were undervalued & taken over.
it is a fluid process. They were all significantly different types of companies.
All had one thing in common. A SP that was unjustiably low. Massive bashing of management & those who supported.
Huge unrealized upside.
It is a long painful road being a shareholder of an out of favour company.
However, patience can & does pay off.
The real question, yet to be answered, what is Pelareorep worth?
If the pancreatic cancer cotherapy comes to market....billions.
Management said yrs ago, nothing under a billion would even be considered.
The $6 Ps is about 1/2 that.
mangement would most likely recommend not accepting that offer.
Would Roche, Pfizer, Incyte or any other pharma offer $1,2, 5...$10 billion?
absolutly if they saw the sales/ income potential of Pela & a cotherapy with their in place drugs.
That math, we have no access to.
Way way too many variables & options.
saying it won't happen, because it has not happened yet. Total nonsense
it Might happen! Might not.
We will know when we know.
Assuming it does happen? Predicting a price is again next to impossible.
Great that Merk has a capital investment stratagy in the $1-$10billion range.
if they see a market for Pela & based on that future income, a takeover price will be justified.
Just as Onc has to justify a sellout price, the aquiring comany has to justify a takeover price.
So far those two sides of the negotiation have not come to an agreement.
Have there been negotiations? Again, information we would only know after the fact.
Undisclosed theory indicates Pfizer is waiting to see the longer term results of bracelet.
Roche?
three out of the 4 Gobblet trial cohorts have shown positive results. The pancreatic cancer gained quickly fast track approval, from FDA.
Roche being the most likely candidate as a takeover candidate.
all I can say is stay tuned......
As a new potential investor reading this?
The downside is measured in cents, the upside in dollars.
Biotechs have huge risk.
stay tuned....